Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
Arkansas Children's Hospital, Little Rock, Arkansas Velocity Clinical Research, Washington DC, Washington D.C., District of Columbia Coastal Heritage Clinical Research, Hinesville, Georgia Clinical Research Institute, Minneapolis, Minnesota Children's Hospital & Medical Center, Omaha, Nebraska True North Neurology, Port Jefferson Station, New York Accellacare - Piedmont, Statesville, North Carolina Accellacare of Piedmont HealthCare, Statesville, North Carolina Accellacare US Inc., Winston-Salem, North Carolina Central States Research, Tulsa, Oklahoma Cedar Health Research, Dallas, Texas Wasatch Clinical Research, LLC, Salt Lake City, Utah Granger Medical Holladay - Holladay Clinic, Salt Lake City, Utah